GLI3 and Pallister-Hall syndrome: While, loss-of-function mutations that lead to a reduction of GLI3 protein and haploinsufficiency in the patients are responsible for GCPS [5], [12], [17], truncating mutations resulting in dominant negative effects and gain-of-function of the repressor peptide cause PHS [6], [16].